The Stanley Laboratory of the Johns Hopkins University
The Stanley Laboratory was founded in 1996 to promote research into the role of infectious agents in the etiology and pathogenesis of schizophrenia and bipolar disorder. The Stanley Laboratory is fully supported by the Stanley Medical Research Institute (www.stanleyresearch.org). Some of the scientific background of the Laboratory’s research studies can be found here. Recent publications can be found here.
Some of the activities of the Stanley Laboratory include:
A post doctoral Fellowship Program which provides training the field of neurovirology, neuropathology and the epidemiology of serious psychiatric diseases.
An annual symposium on a topic related to the biology of brain diseases.
Serologic studies. We have a robotic system which can perform large scale analyses of serum and cerebrospinal fluids for antibodies to a range of infectious agents including Herpes Simplex Virus Type 1, Herpes Simplex Virus Type 2, Cytomegalovirus, Epstein-Barr Virus, Human Herpes Virus Type 6, Toxoplasma gondii, Influenza A Virus and Influenza B virus. These assays are performed free of charge for collaborators.
Scientific Collaborations: The Stanley Laboratory is interested in the performance of collaborative studies with laboratories interested in the study of human psychiatric diseases. Some of the ongoing collaborating institutions are:
Department of Neurovirology, Karolinsk Institute, Stockholm Sweden
Department of Psychiatry, University of Heidelberg
Department of Psychiatry, University of Cologne
Department of Epidemiology, Harvard School of Public Health
Department of Pharmacology, University of Maryland
Department of Psychiatry, University of Cambridge
Department of Medical Microbiology, Washington University of St. Louis
Department of Psychology, Sheppard Pratt Health System, Baltimore, MD
Roveko Laboratories, Gaithersburg, MD